Labixiaoxin Snacks Group Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Labixiaoxin Snacks Group.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Food earnings growth	14.0%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

Recent updates

Market Cool On Labixiaoxin Snacks Group Limited's (HKG:1262) Revenues

Dec 06

We Discuss Why Labixiaoxin Snacks Group Limited's (HKG:1262) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Jun 11

Labixiaoxin Snacks Group Limited (HKG:1262) Stock's 31% Dive Might Signal An Opportunity But It Requires Some Scrutiny

May 10

Labixiaoxin Snacks Group (HKG:1262) Is Experiencing Growth In Returns On Capital

Feb 01

There's Been No Shortage Of Growth Recently For Labixiaoxin Snacks Group's (HKG:1262) Returns On Capital

Oct 28

These 4 Measures Indicate That Labixiaoxin Snacks Group (HKG:1262) Is Using Debt Extensively

Sep 23

Labixiaoxin Snacks Group (HKG:1262) Shareholders Will Want The ROCE Trajectory To Continue

Apr 03

We Believe Labixiaoxin Snacks Group's (HKG:1262) Earnings Are A Poor Guide For Its Profitability

Oct 06

Is Labixiaoxin Snacks Group (HKG:1262) A Risky Investment?

Apr 01

How Should Investors React To Labixiaoxin Snacks Group's (HKG:1262) CEO Pay?

Dec 08

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Labixiaoxin Snacks Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SEHK:1262 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2024	846	-144	0	37	N/A
3/31/2024	805	-124	28	63	N/A
12/31/2023	764	-105	55	89	N/A
9/30/2023	756	-90	63	99	N/A
6/30/2023	748	-75	71	110	N/A
3/31/2023	716	-75	33	63	N/A
12/31/2022	684	-75	-5	15	N/A
9/30/2022	660	-86	-20	-3	N/A
6/30/2022	635	-98	-35	-22	N/A
3/31/2022	642	-81	-96	-79	N/A
12/31/2021	648	-65	-157	-135	N/A
9/30/2021	634	5	-165	-147	N/A
6/30/2021	620	75	-174	-159	N/A
3/31/2021	564	23	-98	-86	N/A
12/31/2020	509	-29	-22	-12	N/A
9/30/2020	481	-109	-43	-33	N/A
6/30/2020	454	-189	-64	-53	N/A
3/31/2020	460	-179	-20	-9	N/A
12/31/2019	467	-170	24	35	N/A
9/30/2019	473	-177	64	77	N/A
6/30/2019	480	-185	104	119	N/A
3/31/2019	491	-182	89	104	N/A
12/31/2018	503	-180	74	89	N/A
9/30/2018	628	-234	-4	36	N/A
6/30/2018	754	-287	-83	-18	N/A
3/31/2018	828	-288	N/A	-43	N/A
12/31/2017	903	-289	N/A	-69	N/A
9/30/2017	908	-384	N/A	-1	N/A
6/30/2017	913	-478	N/A	67	N/A
3/31/2017	903	-540	N/A	-6	N/A
12/31/2016	893	-602	N/A	-78	N/A
9/30/2016	892	-566	N/A	-101	N/A
6/30/2016	891	-530	N/A	-124	N/A
3/31/2016	969	-434	N/A	-31	N/A
12/31/2015	1,047	-338	N/A	62	N/A
9/30/2015	1,066	-162	N/A	131	N/A
6/30/2015	1,085	15	N/A	200	N/A
3/31/2015	1,107	13	N/A	159	N/A
12/31/2014	1,129	11	N/A	118	N/A
9/30/2014	1,301	81	N/A	89	N/A
6/30/2014	1,473	150	N/A	60	N/A
3/31/2014	1,653	238	N/A	200	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 1262's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if 1262's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 1262's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 1262's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 1262's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 1262's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 04:44
End of Day Share Price	2025/01/02 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Labixiaoxin Snacks Group Limited is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jenny Chan	BOCI Research Ltd.
Yuan Yuan Ji	Haitong International Research Limited
Nicolas Wang	Haitong International Research Limited (Inactive)

Labixiaoxin Snacks Group Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Labixiaoxin Snacks Group Limited Provides Earnings Guidance for the Six Months Ended June 30, 2022

Labixiaoxin Snacks Group Limited Provides Unaudited Earnings Guidance for the Six Months Ended June 30, 2021

Labixiaoxin Snacks Group Limited Provides Group Earnings Guidance for the Year Ended 31 December 2020

Recent updates

Market Cool On Labixiaoxin Snacks Group Limited's (HKG:1262) Revenues

First half 2024 earnings released: CN¥0.33 loss per share (vs CN¥0.036 loss in 1H 2023)

Labixiaoxin Snacks Group Limited to Report First Half, 2024 Results on Aug 29, 2024

New major risk - Shareholder dilution

New major risk - Market cap size

We Discuss Why Labixiaoxin Snacks Group Limited's (HKG:1262) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Labixiaoxin Snacks Group Limited (HKG:1262) Stock's 31% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Is Labixiaoxin Snacks Group (HKG:1262) Using Too Much Debt?

Labixiaoxin Snacks Group Limited, Annual General Meeting, Jun 18, 2024

Full year 2023 earnings released: CN¥0.08 loss per share (vs CN¥0.057 loss in FY 2022)

Labixiaoxin Snacks Group Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

New minor risk - Share price stability

Is Labixiaoxin Snacks Group (HKG:1262) Weighed On By Its Debt Load?

A Look At The Fair Value Of Labixiaoxin Snacks Group Limited (HKG:1262)

First half 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.004 loss in 1H 2022)

Labixiaoxin Snacks Group Limited to Report First Half, 2023 Results on Aug 30, 2023

Now 21% undervalued after recent price drop

Full year 2022 earnings released: CN¥0.06 loss per share (vs CN¥0.049 loss in FY 2021)

Labixiaoxin Snacks Group (HKG:1262) Is Experiencing Growth In Returns On Capital

Less than half of directors are independent

There's Been No Shortage Of Growth Recently For Labixiaoxin Snacks Group's (HKG:1262) Returns On Capital

These 4 Measures Indicate That Labixiaoxin Snacks Group (HKG:1262) Is Using Debt Extensively

Labixiaoxin Snacks Group Limited Announces Board and Committee Changes

First half 2022 earnings released: CN¥0.004 loss per share (vs CN¥0.021 profit in 1H 2021)

Labixiaoxin Snacks Group Limited to Report First Half, 2022 Results on Aug 29, 2022

Labixiaoxin Snacks Group Limited Provides Earnings Guidance for the Six Months Ended June 30, 2022

Full year 2021 earnings released: CN¥0.049 loss per share (vs CN¥0.022 loss in FY 2020)

Labixiaoxin Snacks Group Limited, Annual General Meeting, Jun 23, 2022

Less than half of directors are independent

Labixiaoxin Snacks Group (HKG:1262) Shareholders Will Want The ROCE Trajectory To Continue

Full year 2021 earnings released: CN¥0.05 loss per share (vs CN¥0.022 loss in FY 2020)

We Believe Labixiaoxin Snacks Group's (HKG:1262) Earnings Are A Poor Guide For Its Profitability

First half 2021 earnings released: EPS CN¥0.021 (vs CN¥0.058 loss in 1H 2020)

Labixiaoxin Snacks Group Limited Provides Unaudited Earnings Guidance for the Six Months Ended June 30, 2021

Full year 2020 earnings released: CN¥0.02 loss per share (vs CN¥0.13 loss in FY 2019)

Is Labixiaoxin Snacks Group (HKG:1262) A Risky Investment?

Labixiaoxin Snacks Group Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

Labixiaoxin Snacks Group Limited Provides Group Earnings Guidance for the Year Ended 31 December 2020

New 90-day low: HK$0.24